PEOPLE - Changes at Andaris (UK):
This article was originally published in Clinica
Executive Summary
Andaris, a UK developer of in vivo imaging and therapeutic products, has appointed Dr Stuart Collinson of Glaxo Wellcome CEO. David Heath, Andaris' lead founder, has retired as chairman but remains a non-executive director and consultant to the UK company. Gordon Hall, previously managing director of Shield Diagnostics, joins as non-executive chairman.